Prolonged overall survival in gastric cancer patients after adoptive immunotherapy - Wikidata - awgldk - TriplyDB

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

http://www.wikidata.org/entity/Q35152386

about

Cellular immunity augmentation in mainstream oncologic therapy Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysis.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancer.Optimizing Radiotherapy with Immunotherapeutic Approaches.Disappearance of bone metastases in chemotherapy-resistant gastric cancer treated with antigen peptide-pulsed dendritic cell-activated cytotoxic T lymphocyte immunotherapy: A case report.Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer

P2860

Q38557424-8024013F-9EEC-4678-A0CC-CB8D48EF15BA Q38887317-CF61EC7A-CADE-41A8-BE4F-5712224B67BB Q41110505-485B279E-FA6C-41FD-8F39-9D92E2DDC0E5 Q50083358-5BDF9CB7-863E-48E3-A8EF-EF4A649E2208 Q52888621-A55CA57A-B1A2-477D-B796-A31FFB89A44A Q55404516-C841081E-F3FA-4DE2-91DD-41066E924CBE Q55652343-DC9DA46D-8AAA-4D99-994D-C449AA823882 Q57167306-EDF5E60B-DFEE-441F-BD7B-FA0C792BB20F

P2860

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

http://www.wikidata.org/entity/Q35152386

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@ast

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@en

type

label

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@ast

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@en

prefLabel

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@ast

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@en

P1433

Q35152386-D9EBB8D2-D2A7-42AA-A5F1-26285A96E864

P1476

Q35152386-616B6299-B1E9-486B-BBE2-E0406C2EDF4F

P2093

Q35152386-2844162B-D049-4083-B8DB-B54B0FCF50BB

Q35152386-36B81FF7-474F-4D85-B72A-F7CEBA687C5B

Q35152386-5C5FA059-FE6F-4EE0-BE58-C8435AE94849

Q35152386-682C5222-22A3-4A56-A435-58C56C71D120

Q35152386-6A6DD80A-753D-42F0-8DAF-92D3805E2D5B

Q35152386-7C088011-5B2C-4A81-8011-A74B4D2421E3

Q35152386-7D3D54AA-1114-4B49-B6A2-5CE9EF1EAAC6

Q35152386-7EB921C3-7ED5-47FF-BE43-73165A4C9F63

Q35152386-80500EE9-4DE1-4E29-8EFE-27B6FED2084E

Q35152386-F22282C9-E4BE-4C08-AF04-DC2B5FF961AC

P2860

Q35152386-161BE165-C59F-425C-83F5-A33630B1D331

Q35152386-16CFA4E0-98AE-4675-AFAE-AD92622AC78F

Q35152386-226EC6CD-290C-4DD8-A2FB-A9C80EF8292E

Q35152386-2664C5AA-B86E-44B4-9EE7-C57AB5412B60

Q35152386-32612CD2-FB65-455C-8D0B-1332520854D6

Q35152386-4BC25C51-8FB8-49E2-9083-552815699ACE

Q35152386-5F8F4842-0574-45D5-9C9B-46A649210E7D

Q35152386-60709F80-C7B9-49F7-A0CA-FE4C5A092B82

Q35152386-68B8E04D-4845-4261-AFF5-C90E3D2613BB

Q35152386-70FA8083-1C4E-422E-ABE5-59B286820649

P304

Q35152386-C2B4D8A3-D152-4192-A760-AEAC7DC598D2

P31

Q35152386-5747A12C-CF51-4615-9520-2D1B7C0BA9A6

P356

Q35152386-49B8E7CF-92A2-429C-8A33-337A27CDD212

P407

Q35152386-9692A486-6F02-4D57-B5C6-A59067317359

P433

Q35152386-47AF22C4-A9E6-4222-8F29-1BA4E395464A

P478

Q35152386-B8DC28F3-56A3-4ECB-BF05-5F194AC40950

P50

Q35152386-DEFBF534-D749-413D-B8A3-D51CC6DEE41B

P577

Q35152386-5B8F085A-D4FD-4F98-BDC7-BD38B7912EB3

P5875

Q35152386-E7C55220-4AED-4D5F-86BE-79EC8FA69E03

P698

Q35152386-53EBEDC2-9DAF-4BE7-84AA-6417D5D6A1A4

P921

Q35152386-BC797456-BCEE-484F-B3B4-0A9AA2962029

P932

Q35152386-FCC7B0C7-340D-45D5-BDA5-0BCA752CB16F

P356

WJG.V21.I9.2777

P1433

World Journal of Gastroenterology

P1476

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

@en

P2093

Gang Wang

http://www.w3.org/2001/XMLSchema#string

Guo-Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Jian-Yu Wu

http://www.w3.org/2001/XMLSchema#string

Jin-Yu Li

http://www.w3.org/2001/XMLSchema#string

Liang-Liang Wu

http://www.w3.org/2001/XMLSchema#string

Xiang Yan

http://www.w3.org/2001/XMLSchema#string

Xiao-Gang Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Shao

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy for cancer: building on success

Adoptive T cell therapy for cancer in the clinic

Cancer immunoediting: from immunosurveillance to tumor escape

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Cytotoxicity of activated natural killer cells against pediatric solid tumors.

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)

Dendritic cell immunotherapy for cancer: application to low-grade lymphoma and multiple myeloma.

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

A fresh look at tumor immunosurveillance and immunotherapy.

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.

P304

2777-2785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I9.2777

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273469580

http://www.w3.org/2001/XMLSchema#string

P698

25759549

http://www.w3.org/2001/XMLSchema#string

P921

P932

4351231

http://www.w3.org/2001/XMLSchema#string